Pfizer has announced the approval of HYMPAVZI by the US Food and Drug Administration (FDA) for patients with haemophilia A ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...

The FDA granted the approval of Hympavzi to Pfizer Inc.

Pfizer announced on Friday that the U.S. Food and Drug Administration has granted approval for its once-weekly injection ...

Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market.

Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 14:10 Hrs [IST] Pfizer ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Robert F. Kennedy, Jr. has been antivax for two decades. His fellow travelers are not happy about his leaving out vaccines in ...

Mr Lowe said that while he was not opposed to vaccines, his life had been destroyed. The Public Health Agency (PHA) said the ...

We recently compiled a list of the 10 Most Profitable NASDAQ Stocks To Invest In. In this article, we are going to take a ...

Indegene Digital Summit on Oct 17 & 18 to have pharma chiefs dwell on GenAI and commercialization strategy: Our Bureau, Bengaluru Monday, October 14, 2024, 09:00 Hrs [IST] Indegen ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...